Clearway Health in the News: 2024
Key Takeaways
- Clearway Health’s 2024 media coverage reinforces leadership in specialty pharmacy innovation and access to advanced therapies.
The breadth of placements across healthcare, business and trade publications highlights Clearway Health’s role in expanding access to gene and cell therapies, improving specialty pharmacy models and supporting health system transformation. This strengthens topical authority around “specialty pharmacy expansion,” “gene therapy access” and “health system pharmacy innovation.” - Gene and cell therapy initiatives emerged as the most prominent and high-impact storyline.
Coverage repeatedly centers on breakthrough programs such as supporting Children’s National Hospital in delivering high-cost gene therapies (e.g., ZYNTEGLO® for beta-thalassemia) and building operational models for cell and gene therapy delivery. This reinforces expertise in “cell and gene therapy pathways,” “care delivery models” and “complex drug access programs.” - Thought leadership and health system partnerships position Clearway Health as an industry advisor, not just a service provider.
In addition to operational success stories, Clearway Health is frequently cited in strategic discussions on payer networks, 340B programs, GLP-1 medications and pharmacy leadership. This expands relevance across executive-level healthcare topics like “pharmacy strategy,” “health system revenue growth” and “care access optimization.”
Clearway Health in the News: 2024
Health Leaders
Is Pharmacy Expansion an Effective RX For Health Systems?
ABC News – Medwatch
Specialty pharmacy receives URAC award
Healthcare Finance News
Children's National Hospital partners for expensive gene therapy
Forbes Business Council
Four Important Practices Amid GLP-1 Medications Reshaping Healthcare
This was an exciting year for Clearway Health news coverage! There were many important 2024 milestones and accomplishments featured in business, healthcare, pharmacy and local publications.
We jump started 2024 with the announcement of Clearway Health’s launch of a model to support health systems in enabling access to breakthrough gene therapy. Our work in helping Children’s National Hospital treat their first pediatric patient with ZYNTEGLO®, a gene therapy treatment for beta-thalassemia was a news highlight. Clearway Health specialty pharmacy stories, health system partnerships and industry expertise garnered attention throughout the year. Highlighted below are Clearway Health’s 2024 news placements.
Gene and Cell Therapy News:
1) Healthcare Finance News
Children's National Hospital partners for expensive gene therapy
2) Becker’s Hospital Review
Children's National Hospital taps Clearway to deliver $2.8M gene therapy
3) Specialty Pharmacy Continuum
Pediatric Hospital Gets Help Navigating CGT Pathway
4) Pharmacy Practice News
CGTs ‘a Big Deal for Pharmacy,’ So Getting Payment Right Is Crucial
5) AM Intelligence
Specialty Pharmacy Accelerator Clearway Health Implements New Gene Therapy Model
6) CGTLive
Around the Helix: Cell and Gene Therapy Company Updates – February 7, 2024
7) Pharmacy Angle
Clearway Health Launches Model Enabling Access to Breakthrough Gene Therapy
8) Chief Healthcare Executive
Six steps healthcare leaders should consider before launching a cell and gene therapy program
Specialty Pharmacy News:
1) Specialty Pharmacy Continuum
Specialty Pharmacy Partnership Can Be Fertile Ground
2) Health Leaders
Is Pharmacy Expansion an Effective RX For Health Systems?
3) Health Leaders
Is Pharmacy Expansion Right For Your Health System?
Health System Partnership News:
1) The Brooklyn Eagle
Brooklyn Hospital Center, Clearway Health Partner on Meeting New Hepatitis Screening Rules
2) Pharmacy Angle
Executive Interview with Robert DiGregorio and Allison Arant
3) Pharmacy Angle
Baptist Health and Clearway Health Partner to Augment Footprint in Payor Networks
4) Becker’s Hospital News
Baptist reinforces payer strategy, forecasts $100M revenue boost
5) ABC News – Medwatch
Specialty pharmacy receives URAC award
6) Health Leaders
Healthcare Leaders Are Redefining Hospital Pharmacy
Clearway Health Industry Expertise in the News:
1) Pharmacy Angle
Could More Small and Rural Hospitals Fully Utilize the 340B Drug Pricing Program?
2) Pharmacy Times
Essential Hospitals Can Redirect 2025 Medicare Part D Cap Funds to Serve Disadvantaged Patients, Communities
3) Healthcare Innovation
An Open Healthcare Technology System: A Catalyst for Long-Term Innovation
4) MedCity News
Why Every Hospital Needs a Chief Pharmacy Officer in the C-Suite
5) Forbes Business Council
18 Tips to Enhance Your Business's Overall Team Strategy
6) Pharmacy Times
Optimizing a Health System’s Access to Novel Therapies, Payor Networks Can Keep Drug Costs Down
7) Forbes Business Council
16 Biz Experts Detail How To Prioritize Growth OrProfit Successfully
8) Courier Journal
Louisville's Baptist Health hopes new partnership will lower costs for specialty drugs
9) Chief Healthcare Executive
Six steps healthcare leaders should consider before launching a cell and gene therapy program
10) Authority Magazine/Medium
Women Of The C-Suite: Nicole Faucher On The Five Things You Need To Succeed As A Senior Executive
11) Forbes Business Council
Four Important Practices Amid GLP-1 Medications Reshaping Healthcare
America’s Essential Hospital’s Blog:
1) America’s Essential Hospitals
During National Pharmacy Week, Essential Hospitals Highlight Importance of 340B Drug Pricing Program
2) America’s Essential Hospitals
Pharmacists Practice Medication Therapy Management to Improve Patient Safety